New blood test cutoff could spot hidden cause of high blood pressure
NCT ID NCT07621458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a new cutoff for a blood test (aldosterone-renin ratio) can better identify people with primary aldosteronism, a common cause of high blood pressure. About 150 adults with hypertension and certain lab results will be tested using the new cutoff and then followed after treatment. The goal is to see how many tests are needed to find one case and to find the best cutoff for Korean patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital
RECRUITINGSeoul, Korea, Republic of, 03080, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••